Product Images Venlafaxine Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Venlafaxine Hydrochloride NDC 0615-7622 by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

00093738556

00093738556

00093738656

00093738656

venlafaxine er caps 75 150mg 0093 1

venlafaxine er caps 75 150mg   0093 1

This is a table displaying drug interactions and analyte data. The interacting drugs listed are Ethanol, Dlazepam, Clmetidine, Ketoconazole, Indinavir, Metoprolol, Imipramine, and Lithium. The analyte listed is venlafaxine. The table contains PK fold change and 90% Cl recommendations for Ccmax, AuC, Cmax, and Auc for each drug interaction. The recommendations include avoiding concomitant use, no dose adjustment, and using with caution in patients with hypertension, elderly or hepatic dysfunction. There is also a note to monitor blood pressure when using some of the interactions.*

venlafaxine er caps 75 150mg 0093 2

venlafaxine er caps 75 150mg   0093 2

This is a list of drugs and their interactions with each other and analytes. The list includes ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide and lithium. The table further describes their PKFold change and 90% CRecommendation, Cmax and AuC, as well as any potential dose adjustments or cautions for use.*

venlafaxine er caps 75 150mg 0093 3

venlafaxine er caps 75 150mg   0093 3

This text describes recommendations for adjusting the dosage of certain analytes based on various factors such as hepatic and renal impairment, CYP2D6 polymorphism, gender, and age. The analytes listed include Enlafaxine, Enlataxine, and Venlafaxine. The recommendations suggest reducing doses by various percentages or individualizing dosing as necessary. The text also includes a chart showing fold change and 90% confidence interval recommendations for adjusting dosages.*

venlafaxine er caps 75 150mg 0093 4

venlafaxine er caps 75 150mg   0093 4

The text is a chemical formula that seems to be incomplete and followed by the name of a chemical compound "venlafaxine hydrochloride". No further information can be extracted from this text.*

venlafaxine er caps 75 150mg 0093 5

venlafaxine er caps 75 150mg   0093 5

This is a medication package for Venlafaxine HCI ER Caps USP, which contains 75mg of venlafaxine hydrochloride. The package is manufactured by Teva Pharmaceuticals with a NDC code for tracking. The medication is only for prescription as it says, Rxonly. The package should be stored at a temperature of 20°C- 25°C (68°F- 77°F). The medication should not be exposed to light and should be dispensed in a tightly covered container. It is for institutional use only and the dosage information should be read from the insert inside or from the label. There are various Lot numbers for the medication, and it has been packaged by Vangard located at Glasgow, KY 42141.*

venlafaxine er caps 75 150mg 0093 6

venlafaxine er caps 75 150mg   0093 6

This is a medication package of Venlafaxine HCI (ER Caps USP) with dosage 150mg, LOT number 7622 and expiry date not mentioned, manufactured in Israel for Teva USA. It's been packaged by Vanguard in Glasgow, KY, USA. It has to be stored at 20-25°C (68-77°F) and protected from light. The package contains capsules equivalent to 150mg venlafaxine hydrochloride, and its usage instructions should be followed, as stated on the label.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.